S22-437 Hypoallogenic-Immunogenic Pluripotent Stem Cells as an Anti-cancer Vaccine Stanford researchers in the Wu Lab have developed hypoallergenic and immunogenic induced pluripotent stem cells that could be used as a cancer treatment or prophylactic. Lin Wang Joseph Wu